Introduction
A previous study in patients with homozygous sickle-cell disease aged over 401 indicated a strong positive correlation between haemoglobin concentration and creatinine clearance. Haemoglobin concentrations appeared to be adversely affected by fairly minor degrees of renal insufficiency, and we postulated that the bone marrow might be very sensitive to reduced erythropoietin concentrations. We investigated this possibility further by measuring serum concentrations of erythropoiesisstimulating factor, renal function, and haemoglobin concentrations in 31 adults with sickle-cell disease who were in a steady state (that is, free of acute complications of their disease) at the time of study.
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Patients and methods
Patients with sickle-cell disease were chosen from those attending the sickle-cell clinic of the University Hospital of the West Indies, Jamaica, on the basis of their willingness to take part in the study. Each was admitted electively to hospital when free of acute complications of their disease. The diagnosis of sickle-cell disease was based on a single major haemoglobin band in the position of haemoglobin S on cellulose acetate and agar-gel electrophoresis, compatible haemoglobin A2 concentrations, and family study when possible. No patient had received a transfusion within three months, and only two had been included in the earlier study. ' Creatinine clearance was determined from two consecutive 24-hour collections of urine and accompanying measurements of serum creatinine concentration, and the result was expressed as the mean of the two estimations, corrected for surface area derived from height and weight. Blood was drawn for measurement of serum urea concentration and standard haematological variables. Erythropoiesisstimulating factor was measured by a modification of the fetal mouse liver cell assay described by Wardle et a12 using sera stored without preservative at -70'C and thawed only once, just before the estimation. After overnight incubation of cell cultures in the presence of either test serum or pooled normal serum supplemented with sheep erythropoietin (stage III, Connaught Laboratories) activity of erythroid precursor cells was measured by the rate of incorporation of iron-59-labelled ferrous citrate into haem. Differences in uptake of 59Fe because of differences in the iron content of sera were prevented by adding an excess of human transferrin. The mean normal values for this laboratory in 11 male and 10 female American subjects were 12-8 U/I (range 4-5-19 8 U/I) and 17-2 U/I (range 10-8-27-0 U/1) respectively.
Student's t test and linear regression were used for statistical testing of results. As noted by others,3 concentrations of erythropoiesisstimulating factor had a skewed distribution, and logarithmic transformation was therefore performed before analysis.
Results
The study group consisted of 11 men and 20 women with a mean age of 37-1 years (range 15-66 years). Five were already known to have renal failure (creatinine clearance 4-23 ml/min/1-73 m2n) accompanied by appreciable anaemia (haemoglobin concentration 3-0-4-9 g/dl). Two of these (women aged 64 and 65 years) had been included in our earlier report: each had had slowly worsening anaemia and loss of renal function for which no explanation other than sickle-cell disease could be found. Of the other patients with known renal failure, one, a 50-year-old woman, had had an episode of the nephrotic syndrome nine years earlier followed by progressive loss of renal function, while a 48-year-old man and a 30-year-old woman had been found to be uraemic when investigated because of worsening anaemia. Histology in two patients (one at necropsy and one at biopsy) indicated changes typical of older patients with sicklecell disease and no evidence of an inflammatory.glomerulonephritis. In addition to these patients a further 12 were found to have clinically unsuspected mild renal impairment (creatinine clearance less than 100 ml/min/1-73 m2n) and haemoglobin concentrations ranging from 5-4 to 11-0 g/dl.
Haemoglobin concentrations ranged from 3-0 to 11-0 g/dl and showed a weak negative correlation with age (r = -048, p <0-01).
Creatinine clearance ranged from 4 to 191 ml/min/1-73 m2 and fell significantly with age (r = -0-66, p <0-001). The relation between haemoglobin concentration and creatinine clearance (fig 1) was similar to that found in patients over 40 years old,' with a significant positive correlation (r= 0-58, p <0-001). As before, the effect of renal function on haemoglobin concentration appeared to be strongest in patients with a creatinine clearance of less than 100 ml/min/I-73 M2.
Concentrations of erythropoiesis-stimulating factor ranged from 2-1 to 21-9 U/1. There was a strong correlation between haemoglobin concentration and the concentration of the factor (fig 2; r=0-65, p <0-001), and this was also strongest in patients with a creatinine clearance of less than 100 ml/min/1-73 m'. The concentration of erythropoiesis-stimulating factor was correlated positively with creatinine clearance (fig 3; r=0-61, p <0-001) and inversely with serum urea concentration (r = 0-58, p < 0-001). There was no relation between the percentage reticulocyte count and haemoglobin concentration (r= -0-19), and the patients with a fairly low creatinine clearance (less than 100 ml/min/1-73 m2) had lower absolute reticulocyte counts (mean ± SD: 212 ± 91 x 109/l) than the remainder of the group (323 ± 159 x 109/l; p < 0-05), supporting the hypothesis that marrow hypoplasia was responsible for the lower haemoglobin concentrations. 
Discussion
Published reports show that in sickle-cell disease erythropoietin concentrations rise in response to a fall in haemoglobin concentration as in aplastic crisis.45 Though reports have not always made clinical details clear, it appears that serum erythropoietin concentrations in asymptomatic patients may be either normal or raised and are negatively correlated with haemoglobin concentration.5-7 Any increase above normal, however, is less than that observed in other anaemic states with similar haemoglobin concentrations,3 6 perhaps because reduced oxygen affinity in sickle-cell disease makes tissue hypoxia (the stimulus to erythropoietin production) unusual in patients with steadystate haemoglobin concentrations. This may explain our observation that none of the 31 patients had a concentration of erythropoiesis-stimulating factor above the normal range. The expanded and hyperactive erythron in sickle-cell disease can therefore function with normal serum erythropoietin concentrations, although it is possible that the rate of production of erythropoietin is high and that the hormone is rapidly consumed by active marrow cells.8
Our present results agree with the earlier findings that low haemoglobin concentrations in patients with steady-state sickle-cell disease are associated with renal insufficiency and that this phenomenon is particularly characteristic of patients over 40 years old. ' Haemolysis consequent on uraemia is unlikely to contribute to the anaemia since reticulocyte counts were not raised, and the correlations between concentrations of haemoglobin and erythropoiesis-stimulating factor and between the concentration of the factor and creatinine clearance suggest that reduced production of erythropoietin is responsible. The correlation between concentrations of haemoglobin and erythropoiesis-stimulating factor was most evident in those patients with a fairly low creatinine clearance, which shows that the erythropoietin concentration becomes the important limiting factor in red-cell production only when renal insufficiency is present.
In most reports of bioassays of erythropoietin in chronic renal failure concentrations are either below normal or raised to a lower degree than might be expected for the extent of anaemia,9-12 whereas immunological methods have produced values well in excess of those expected,1' 14 leading to the suggestion that either circulating erythropoietin is inactive or an inhibitor is present. The effects of differing types of renal disease and of haemodialysis are unknown, and our patients represented an unusual opportunity to examine the interrelations of haemoglobin concentration, erythropoietin concentration, and renal function without these complicating factors. All test sera stimulated the erythropoietic activity of the culture system, but the extent of stimulation might possibly have been limited by the presence of uraemic toxins. This is unlikely, however, because few patients were more than mildly uraemic. All except three had serum urea concentrations below 16-0 mmol/l (96 mg/100 ml) and serum creatinine concentrations below 220 tmol/l (2-5 mg/100 ml), values that are not usually associated with uraemic complications in people without sickle-cell disease. Thus glomerular function as measured by creatinine clearance appears to be closely related to capacity to produce erythropoietin. Progressive renal failure is common in older patients with sickle-cell disease' and is one of the commonest causes of death in those aged over 30. 15 The mechanism is poorly understood but is reflected histologically in progressive glomerular damage and cortical scarring, and functionally in reduced production of erythropoietin and falling haemoglobin concentration. The common clinical presentation is of worsening anaemia together with heart failure that further compromises renal function. Survival may be prolonged by chronic transfusion, but since the fall in haemoglobin concentration appears to be determined predominantly by low erythropoietin concentrations it might be amenable to treatment with bone-marrow stimulants such as steroids or prostaglandins. The effects of prostaglandin El infusion on nailfold capillary haemodynamics were studied in eight patients with Raynaud's phenomenon secondary to progressive systemic sclerosis. Using a modified Landis microinjection technique the mean (-SEM) transcapillary pressure gradient was increased during and six weeks after infusion by 13 9-1-32 cm H,O (p <0 05) and 5-5+ 2 5 cm H.O (p <0 05) respectively. Capillary red cell velocity measured in two patients by video television microscopy also increased during and after infusion with prostaglandin E1. Six patients claimed subjective benefit and in three their ulcers healed. These findings support Introduction The vascular abnormalities found in progressive systemic sclerosis constitute a prominent feature of the disease and mainly affect the microvascular circulation.' This association has led some workers to conclude that a microangiopathy might represent the underlying cause of the disease.2 Raynaud's phenomenon is a common and often early feature of the condition and the characteristic attacks of digital exsanguination may result in painful ischaemic ulceration, occasionally leading to gangrene that requires amputation.
Objective assessment of treatment efficacy for Raynaud's phenomenon associated with progressive systemic sclerosis has proved difficult, partly owing to the specialised nature of the circulation in the hand. Conventional assessment using radiometry, thermography, or plethysmography cannot distinguish
